variables
Data license: CC-BY
215 rows where datasetId = 5996 sorted by id descending
This data as json, CSV (advanced)
Suggested facets: unit, createdAt, updatedAt, display, createdAt (date), updatedAt (date)
| id ▲ | name | unit | description | createdAt | updatedAt | code | coverage | timespan | datasetId | sourceId | shortUnit | display | columnOrder | originalMetadata | grapherConfigAdmin | shortName | catalogPath | dimensions | schemaVersion | processingLevel | processingLog | titlePublic | titleVariant | attributionShort | attribution | descriptionShort | descriptionFromProducer | descriptionKey | descriptionProcessing | licenses | license | grapherConfigETL | type | sort | dataChecksum | metadataChecksum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 686700 | Hospital pharmaceutical market (Market: % share of generics (volume)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:12 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | hospital_pharmaceutical_market__market__pct_share_of_generics__volume | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#hospital_pharmaceutical_market__market__pct_share_of_generics__volume | 1 | [] |
float | [] |
a0b3f655137fc0d872e5afc190e32716 | e2439a3765913e197db28c45af9cce26 | |||||||||||||||||||
| 686699 | Community pharmacy market (Market: % share of generics (volume)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:12 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | community_pharmacy_market__market__pct_share_of_generics__volume | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#community_pharmacy_market__market__pct_share_of_generics__volume | 1 | [] |
float | [] |
49800617c3aa926840851e7045025277 | e01cb9067029d3c5c747d7f12ee22247 | |||||||||||||||||||
| 686698 | Hospital pharmaceutical market (Market: % share of generics (value)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:12 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | hospital_pharmaceutical_market__market__pct_share_of_generics__value | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#hospital_pharmaceutical_market__market__pct_share_of_generics__value | 1 | [] |
float | [] |
e4a5c4d8b3ec219563851cb79736ad7e | 2f12ae0749d468267fbc22bdeac51a2a | |||||||||||||||||||
| 686697 | Community pharmacy market (Market: % share of generics (value)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:12 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | community_pharmacy_market__market__pct_share_of_generics__value | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#community_pharmacy_market__market__pct_share_of_generics__value | 1 | [] |
float | [] |
6ea3e7ae0428935648c7336328d6f61d | 96f7c6e5042e88fe348eed5f5b21df96 | |||||||||||||||||||
| 686696 | Third-party-payer market (Market: % share of generics (volume)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | third_party_payer_market__market__pct_share_of_generics__volume | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#third_party_payer_market__market__pct_share_of_generics__volume | 1 | [] |
float | [] |
06ce3f326adda9cc822c737d1b2aef52 | 53fd4fbd7d8d19ad55ae2d3983e6d296 | |||||||||||||||||||
| 686695 | Third-party-payer market (Market: % share of generics (value)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | third_party_payer_market__market__pct_share_of_generics__value | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#third_party_payer_market__market__pct_share_of_generics__value | 1 | [] |
float | [] |
5f66f23d8e5021adfa9d3cf0573667fb | ffe85b5c1bfdfa75aaf27e54bbb13f7c | |||||||||||||||||||
| 686694 | Total pharmaceutical market (Market: % share of generics (volume)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | total_pharmaceutical_market__market__pct_share_of_generics__volume | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#total_pharmaceutical_market__market__pct_share_of_generics__volume | 1 | [] |
float | [] |
5e4a057be2665f592df4b996b0f594c4 | 465eae1cc2505102dc47d5a22d51f8bd | |||||||||||||||||||
| 686693 | Total pharmaceutical market (Market: % share of generics (value)) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | total_pharmaceutical_market__market__pct_share_of_generics__value | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#total_pharmaceutical_market__market__pct_share_of_generics__value | 1 | [] |
float | [] |
6b426ab96d8b0b37fc5cebc70d639563 | bf5fa3ee954579583154ed5b05bf0997 | |||||||||||||||||||
| 686692 | Products not elsewhere classified (Sales: % of total sales) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | products_not_elsewhere_classified__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__pct_of_total_sales | 1 | [] |
float | [] |
bb048774b2584f6584abec5a3b608eda | 8275e91225b6e76ed34aa2d3648ddaca | |||||||||||||||||||
| 686691 | Products not elsewhere classified (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | products_not_elsewhere_classified__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
a20147fe6cf4523f5f3f780eefd1f90f | 845944ee942da31c76bc7ebcaa228417 | |||||||||||||||||||
| 686690 | Products not elsewhere classified (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | products_not_elsewhere_classified__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
596db51d242fd4db03c4175217c26663 | 9c36bd9aba3c80501da6fa28576834dc | |||||||||||||||||||
| 686689 | Products not elsewhere classified (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | products_not_elsewhere_classified__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
33407b5c1e978cfb09e9e25f4c181143 | d7699d01e938809f4dfd601bd9d0dec1 | |||||||||||||||||||
| 686688 | Products not elsewhere classified (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | products_not_elsewhere_classified__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
c4bdd5be1fdd386a81844a188f2b1e5c | 6cfd6d77b928030a0f41af2e872026b5 | |||||||||||||||||||
| 686687 | Products not elsewhere classified (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | products_not_elsewhere_classified__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#products_not_elsewhere_classified__sales__million_of_national_currency_units | 1 | [] |
float | [] |
61a635abaa9af2facc432e2ad9531c15 | 0e3ffcaa39a587b7b7124247a934a92c | |||||||||||||||||||
| 686686 | R03-Drugs for obstructive airway diseases (Sales: % of total sales) | % | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | r03_drugs_for_obstructive_airway_diseases__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__pct_of_total_sales | 1 | [] |
float | [] |
a6eccf6ed8ac180c0809182d30cb7685 | c0fc33db417f695854c59fe29482b7af | |||||||||||||||||||
| 686685 | R03-Drugs for obstructive airway diseases (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:49 | 2024-07-08 16:19:12 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | r03_drugs_for_obstructive_airway_diseases__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
0ed6fa58ef347eab5d665f99482a86b1 | 3f08b8cdd3d495f3bf6dbc0b608983aa | |||||||||||||||||||
| 686684 | R03-Drugs for obstructive airway diseases (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | r03_drugs_for_obstructive_airway_diseases__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
5325156ade2222e33686525f3a9a6044 | e8c35d47cd4b9760c116e37635bfe191 | |||||||||||||||||||
| 686683 | R03-Drugs for obstructive airway diseases (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:49 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | r03_drugs_for_obstructive_airway_diseases__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
0fbb8de83efa6a4b0e8eef6ad7ae0964 | e27f494e18c5332ca801596f957cb6ce | |||||||||||||||||||
| 686682 | R03-Drugs for obstructive airway diseases (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | r03_drugs_for_obstructive_airway_diseases__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
9f5fe4c98b0968632c17fb907d6328d4 | b523894c61fbbaa4061519d26549d945 | |||||||||||||||||||
| 686681 | R03-Drugs for obstructive airway diseases (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | r03_drugs_for_obstructive_airway_diseases__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r03_drugs_for_obstructive_airway_diseases__sales__million_of_national_currency_units | 1 | [] |
float | [] |
a6c923185e4dda91d43d2b74f86c47e8 | 7fba621af5b15737787b4b1fb9c3e638 | |||||||||||||||||||
| 686680 | R-Respiratory system (Sales: % of total sales) | % | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | r_respiratory_system__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__pct_of_total_sales | 1 | [] |
float | [] |
605b05811edb1945099a4b2ed62b0c1b | 61d5cca32f7834d0d8b1e8d9e1ea8195 | |||||||||||||||||||
| 686679 | R-Respiratory system (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | r_respiratory_system__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
a5a74cf80fb5a8a55cf59c132559aeb1 | cd71cd09418b8919dae04ed515205025 | |||||||||||||||||||
| 686678 | R-Respiratory system (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | r_respiratory_system__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
37bf23b9521f47d8c5f10f1c65878386 | 0c48f4f0e05f526515b109e1280d2f9d | |||||||||||||||||||
| 686677 | R-Respiratory system (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | r_respiratory_system__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
725e1b95c9e8cb3a9b4d127ab64aafe4 | 20f4a113655246457db0f074ddc35ea1 | |||||||||||||||||||
| 686676 | R-Respiratory system (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | r_respiratory_system__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
cc224b55de8461f621da7106a6d06201 | fde1d8e70b271b27e693d05934171c9c | |||||||||||||||||||
| 686675 | R-Respiratory system (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | r_respiratory_system__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#r_respiratory_system__sales__million_of_national_currency_units | 1 | [] |
float | [] |
f565ab11d9ac6c396b950e5d6d123db4 | 58d6e7c82ddb30cb4328d790f46f3a4a | |||||||||||||||||||
| 686674 | N06A-Antidepressants (Sales: % of total sales) | % | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | n06a_antidepressants__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__pct_of_total_sales | 1 | [] |
float | [] |
1d07b2b7669cbd09924c3509ef755690 | fc87bebcccab391e11abca867a3b2cea | |||||||||||||||||||
| 686673 | N06A-Antidepressants (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:48 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n06a_antidepressants__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
bfd1982a952161797e23c1efde899099 | 0d79942638273f8bbe664d82a96fd8ef | |||||||||||||||||||
| 686672 | N06A-Antidepressants (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n06a_antidepressants__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
c152a0bcbb537c544f4a85b0af877229 | c475b760ad06eabec794e461bfc38cb7 | |||||||||||||||||||
| 686671 | N06A-Antidepressants (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n06a_antidepressants__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
02eb4869dce91e313d95674f0d5b0f6f | 37ed5c82647eb27bb25eae2fd5ecf024 | |||||||||||||||||||
| 686670 | N06A-Antidepressants (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n06a_antidepressants__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
26b64476914838f672d4c0e0a40f93e9 | 9bcc8549c1a3cfb5fbbc3ccec54d4685 | |||||||||||||||||||
| 686669 | N06A-Antidepressants (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:48 | 2024-07-08 16:19:12 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | n06a_antidepressants__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n06a_antidepressants__sales__million_of_national_currency_units | 1 | [] |
float | [] |
01abc66bb0bc504fa11ce88a6dc221c4 | d1a8d4954bbded14ae01281652027a1a | |||||||||||||||||||
| 686668 | N05C-Hypnotics and sedatives (Sales: % of total sales) | % | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | n05c_hypnotics_and_sedatives__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__pct_of_total_sales | 1 | [] |
float | [] |
ec89d0fec69b55d3d97694697d9e382e | 501f25ac6996a0247e1a28a06b3b2e83 | |||||||||||||||||||
| 686667 | N05C-Hypnotics and sedatives (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n05c_hypnotics_and_sedatives__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
5318ae7ea7d05c31524e6e40128136b7 | 09ec346d1f8ac1dfef5a953054ed7f0a | |||||||||||||||||||
| 686666 | N05C-Hypnotics and sedatives (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n05c_hypnotics_and_sedatives__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
404e36315a4bf5b8268f82820160260a | 429a8fb40624a08de994ffd87f143296 | |||||||||||||||||||
| 686665 | N05C-Hypnotics and sedatives (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n05c_hypnotics_and_sedatives__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
b409e867b137d1c67e0a2c52fc72dafe | 5f8b4f444a9340e90a3309390e6004e7 | |||||||||||||||||||
| 686664 | N05C-Hypnotics and sedatives (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n05c_hypnotics_and_sedatives__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
c09a9e074923f4ce4d9ca5096fbfbd53 | 861dacfbc5332dd411200522afdcb27d | |||||||||||||||||||
| 686663 | N05C-Hypnotics and sedatives (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | n05c_hypnotics_and_sedatives__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05c_hypnotics_and_sedatives__sales__million_of_national_currency_units | 1 | [] |
float | [] |
ac945c11872702a3a07d5106a2abcdb9 | 68b365ea83fb6c7ce58d01976077c317 | |||||||||||||||||||
| 686662 | N05B-Anxiolytics (Sales: % of total sales) | % | 2023-05-04 14:12:48 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | n05b_anxiolytics__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__pct_of_total_sales | 1 | [] |
float | [] |
65a88ca986cfc4a7a23131eb49dc7fe8 | b029e9147ebe0a171f5042263bfd8855 | |||||||||||||||||||
| 686661 | N05B-Anxiolytics (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n05b_anxiolytics__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
36d7023ed1d55d108ce8fef4b64f9709 | aad84f5f9a231fbaab55b2deb6ba15f4 | |||||||||||||||||||
| 686660 | N05B-Anxiolytics (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n05b_anxiolytics__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
f917ffb214196517041bd10c629e6c37 | c3489a9cbf5e705cb17a4da67d07fa2e | |||||||||||||||||||
| 686659 | N05B-Anxiolytics (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n05b_anxiolytics__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
046d7f75eee2f9184ebf7e14162ecc06 | b3685e28ddc76affb157a9e45142a358 | |||||||||||||||||||
| 686658 | N05B-Anxiolytics (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n05b_anxiolytics__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
f17347bd23434639ce4ea5e1856c3547 | c6be0acce3ee2feae957f3034b7b472c | |||||||||||||||||||
| 686657 | N05B-Anxiolytics (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | n05b_anxiolytics__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n05b_anxiolytics__sales__million_of_national_currency_units | 1 | [] |
float | [] |
8367fbd71f1a8b76c9b808da5cbe5b67 | ffa2cc9893c18d6b58c3d331f6458734 | |||||||||||||||||||
| 686656 | N02-Analgesics (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:11 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n02_analgesics__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
0f8a3c5abf1e20487440b8cb2198f4d8 | 73ff6c2ca40853b02ed1e1dbacbb79a7 | |||||||||||||||||||
| 686655 | N02-Analgesics (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n02_analgesics__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
db0d6fee36e1e75b1b71446f527fef19 | f4a51c3edaa18cb2388e1fc0b92ffede | |||||||||||||||||||
| 686654 | N02-Analgesics (Sales: % of total sales) | % | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | n02_analgesics__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__pct_of_total_sales | 1 | [] |
float | [] |
ddcc9f8c6716673c783fd5a4982f0125 | aa0d951979339d6fbdb35fa288179a91 | |||||||||||||||||||
| 686653 | N02-Analgesics (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n02_analgesics__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
971104662821a0475ba5eee0c6a9336b | 372a8f7dd29db7f84c95952785025853 | |||||||||||||||||||
| 686652 | N02-Analgesics (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n02_analgesics__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
ec94e98b85811105eb0c4a543abfa15b | d83e00a67ee45be66e7638228a40c25a | |||||||||||||||||||
| 686651 | N02-Analgesics (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | n02_analgesics__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n02_analgesics__sales__million_of_national_currency_units | 1 | [] |
float | [] |
bf460feba51cd817a06e27a2426ff007 | 11dee5efa7190e3d9a44cd67670b9c7d | |||||||||||||||||||
| 686650 | N-Nervous system (Sales: % of total sales) | % | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | n_nervous_system__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__pct_of_total_sales | 1 | [] |
float | [] |
bd665dc4d104763eceea7b26c94026ce | dcc4a6fab24764c58c87119f2c03c4a5 | |||||||||||||||||||
| 686649 | N-Nervous system (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n_nervous_system__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
c037e4ab9c67c4fab815dc610cecbb8c | 3883b362fd8190e2a454f40a1d679c54 | |||||||||||||||||||
| 686648 | N-Nervous system (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | n_nervous_system__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
2a98428227da3c616715d90cd54382d5 | e231e1def6b3fee49e940feaab9d0e2c | |||||||||||||||||||
| 686647 | N-Nervous system (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n_nervous_system__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
7ebcdd24666ae15c5aa5ca1c6c8d8f5e | 27f8d832eb87ebb139c8d0054c98506a | |||||||||||||||||||
| 686646 | N-Nervous system (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | n_nervous_system__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
77159d3548fb89f79da1b20ba243f197 | d39037568d8de8cd99545db936c16383 | |||||||||||||||||||
| 686645 | N-Nervous system (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | n_nervous_system__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#n_nervous_system__sales__million_of_national_currency_units | 1 | [] |
float | [] |
df7d4667199dfcb132c4b6537bfb0c6c | 547cfe101eda6dd9cb3e4cb10f158229 | |||||||||||||||||||
| 686644 | M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: % of total sales) | % | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__pct_of_total_sales | 1 | [] |
float | [] |
3a84958cc9b290194f2d0c25e1556e6e | 284b6970fd95fd0a57cdc182ab77611c | |||||||||||||||||||
| 686643 | M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
ede945cbf9837f840cf38828d007c3c1 | 5531de695db0497475182cfdfde8d650 | |||||||||||||||||||
| 686642 | M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
2c19462b846f0eda3782e6c0f087fb94 | 47865f861821d7c0b1fc35b2028b6a7a | |||||||||||||||||||
| 686641 | M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
4059f3c3c2bc0229a6eeea8d7fca6bbd | a6a3c4cd0d6ff1ce10e818b37d81fbc8 | |||||||||||||||||||
| 686640 | M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_of_national_currency_units | 1 | [] |
float | [] |
725cf43ddd2b3d86106fe523b13193c4 | 3978b20fddf92303bab12a10ec6f346b | |||||||||||||||||||
| 686639 | M01A-Antiinflammatory and antirheumatic products non-steroids (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m01a_antiinflammatory_and_antirheumatic_products_non_steroids__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
0f90b820225622d0f58613e8594b9f82 | ae7808f5069da3491cd7d4359abf6ec8 | |||||||||||||||||||
| 686638 | M-Musculo-skeletal system (Sales: % of total sales) | % | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | m_musculo_skeletal_system__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__pct_of_total_sales | 1 | [] |
float | [] |
b315b438dc49137a4beef7a69df15731 | b79e6d7153d09ff01304c7fdb64640f9 | |||||||||||||||||||
| 686637 | M-Musculo-skeletal system (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | m_musculo_skeletal_system__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
5b18574aa4f680c9dea7408c989700c2 | 61d0449c69e7904df2ffd63c75fed30e | |||||||||||||||||||
| 686636 | M-Musculo-skeletal system (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | m_musculo_skeletal_system__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
fca741f511370f0d52efc8b7e15af6d7 | c3ba0a601b173103112966b6bf3c2d00 | |||||||||||||||||||
| 686635 | M-Musculo-skeletal system (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:10 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | m_musculo_skeletal_system__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
a67323aea3261c4e5fedad49f82a5417 | be1682052625b9a35c8284fc1160af93 | |||||||||||||||||||
| 686634 | M-Musculo-skeletal system (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | m_musculo_skeletal_system__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
7c643bc3153257db17e4900952eb2518 | e7791093c0bf65b92f61bd531c0b1e32 | |||||||||||||||||||
| 686633 | M-Musculo-skeletal system (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:47 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | m_musculo_skeletal_system__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#m_musculo_skeletal_system__sales__million_of_national_currency_units | 1 | [] |
float | [] |
d78afda6b55852b600f424ad1dc684f1 | 2c33765d658bdbf2d74542279a4c244b | |||||||||||||||||||
| 686632 | J01-Antibacterials for systemic use (Sales: % of total sales) | % | 2023-05-04 14:12:46 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | j01_antibacterials_for_systemic_use__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__pct_of_total_sales | 1 | [] |
float | [] |
fe081624b1c48a23bbc6ef91b0c69166 | 5711b0cb6cbebd785ec5f9dcecf3bdbc | |||||||||||||||||||
| 686631 | J01-Antibacterials for systemic use (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | j01_antibacterials_for_systemic_use__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
41876e9862d2a4d811ada61c28c0559f | 4bd21a4a95b38d9bff69305459fcd0fc | |||||||||||||||||||
| 686630 | J01-Antibacterials for systemic use (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | j01_antibacterials_for_systemic_use__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__million_of_national_currency_units | 1 | [] |
float | [] |
a6eff47e0887df3e8403b3733c99f061 | 3397e374215245adc8d2db5beb2bc8bb | |||||||||||||||||||
| 686629 | J01-Antibacterials for systemic use (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:46 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | j01_antibacterials_for_systemic_use__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
1ceac1de7adf0d5eba08fc42f2810799 | f0b85ddb89bf4502cc8f0f99cd4ec1f0 | |||||||||||||||||||
| 686628 | J01-Antibacterials for systemic use (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:09 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | j01_antibacterials_for_systemic_use__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
824ce797211e7357547b9e7404f638ad | 789de97e7b506430bd0811c05a265574 | |||||||||||||||||||
| 686627 | J01-Antibacterials for systemic use (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | j01_antibacterials_for_systemic_use__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j01_antibacterials_for_systemic_use__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
f03ad3ca6eb36a4cc0685b5f138b73c9 | f1956bbe72e7bfa5f6a063865cea6856 | |||||||||||||||||||
| 686626 | J-Antiinfectives for systemic use (Sales: % of total sales) | % | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | j_antiinfectives_for_systemic_use__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__pct_of_total_sales | 1 | [] |
float | [] |
8854bd90e1b9d1cc85aada62a23ca08d | c41f0b403d2426cbb466f325ae6f5306 | |||||||||||||||||||
| 686625 | J-Antiinfectives for systemic use (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | j_antiinfectives_for_systemic_use__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
d39c14f0d4390553568b7b03d82e05db | 94dce2719c4dd901d9f445187eee0b03 | |||||||||||||||||||
| 686624 | J-Antiinfectives for systemic use (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | j_antiinfectives_for_systemic_use__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
6c4f909a9a9dc8ea41f4973493b7553a | 8f96c9c299036e37ce279d3d26f80f24 | |||||||||||||||||||
| 686623 | J-Antiinfectives for systemic use (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | j_antiinfectives_for_systemic_use__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
33c2373891851ee000c970e22aac56f2 | 87081de6f6620da43b410175003cfd7b | |||||||||||||||||||
| 686622 | J-Antiinfectives for systemic use (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | j_antiinfectives_for_systemic_use__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
f1f857554b42efb36a2adede6eab732a | 9ed47fbcd721bc0b300e43e6d651c57e | |||||||||||||||||||
| 686621 | J-Antiinfectives for systemic use (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | j_antiinfectives_for_systemic_use__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#j_antiinfectives_for_systemic_use__sales__million_of_national_currency_units | 1 | [] |
float | [] |
946afcb9bcaec96b8cead4b325a5af35 | f9ada49e83ceb684e1ba1a3d679996f7 | |||||||||||||||||||
| 686620 | H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: % of total sales) | % | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__pct_of_total_sales | 1 | [] |
float | [] |
8364f58d0c1bec00d942704813dea276 | b412a70e03ec06962b98559e0e27e923 | |||||||||||||||||||
| 686619 | H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
d12b90b98a30c3cc36ebac2f1ceed8c6 | 8b9c2f693ab76f49b23f76eb51daa336 | |||||||||||||||||||
| 686618 | H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
7c5ece29e9821c469b586ca9f321733f | efb4ca731042a31c876e3190d66ba654 | |||||||||||||||||||
| 686617 | H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
f17159175f76dd3d99ad1d5e84dc3ec8 | af18c3f080b5508f76287e1994d086cb | |||||||||||||||||||
| 686616 | H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
fed99bc2205afe275fd06e6f161a93e1 | f4d141ba4cba753ea0a87ca3b1dcdc24 | |||||||||||||||||||
| 686615 | H-Systemic hormonal preparations, excluding sex hormones and insulins (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#h_systemic_hormonal_preparations__excluding_sex_hormones_and_insulins__sales__million_of_national_currency_units | 1 | [] |
float | [] |
73a3f0c4ad1f6f483f677f496c1b64c4 | 1702f78e30cdfbcccd4fb7a82bb9cf48 | |||||||||||||||||||
| 686614 | G03-Sex hormones and modulators of the genital system (Sales: % of total sales) | % | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | g03_sex_hormones_and_modulators_of_the_genital_system__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__pct_of_total_sales | 1 | [] |
float | [] |
aed7b5779385db91bd16bc66386b1c96 | 80c6b2b79a2c809ca192e904db599c31 | |||||||||||||||||||
| 686613 | G03-Sex hormones and modulators of the genital system (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
131eb0257d8249bf151cab553e798d3d | d964e20b875c7da187e11cf317d9ea18 | |||||||||||||||||||
| 686612 | G03-Sex hormones and modulators of the genital system (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:46 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
bb4fbdd060915cc1e3318ea6ccaa7ac7 | cd1387ffe0f20cb6222948c21e838479 | |||||||||||||||||||
| 686611 | G03-Sex hormones and modulators of the genital system (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:45 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
60ba6a910905ba7134124eb295021633 | 103febaa4f1c7632601c4c92eec0df0b | |||||||||||||||||||
| 686610 | G03-Sex hormones and modulators of the genital system (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:45 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
725d822c1fc2700146b7e6f63452e18e | 1ec85971492acbf4dc1cfce58e5f375a | |||||||||||||||||||
| 686609 | G03-Sex hormones and modulators of the genital system (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:45 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g03_sex_hormones_and_modulators_of_the_genital_system__sales__million_of_national_currency_units | 1 | [] |
float | [] |
863bcfc7202f8395d76b859947ca3302 | 2ec67014045c07734d552753b746c575 | |||||||||||||||||||
| 686608 | G-Genito urinary system and sex hormones (Sales: % of total sales) | % | 2023-05-04 14:12:45 | 2024-07-08 16:19:07 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | g_genito_urinary_system_and_sex_hormones__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__pct_of_total_sales | 1 | [] |
float | [] |
2bc7b752bfa1131d2c853a0ba68884fc | 50602e935c8392d5974e64283460fe38 | |||||||||||||||||||
| 686607 | G-Genito urinary system and sex hormones (Sales: US$ (purchasing power parity per capita) | US$ per capita | 2023-05-04 14:12:45 | 2024-07-08 16:19:08 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | g_genito_urinary_system_and_sex_hormones__sales__usd__purchasing_power_parity_per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__usd__purchasing_power_parity_per_capita | 1 | [] |
float | [] |
aee99ac1f486cd58d5a6c75a59a44e8f | 898b6c09cb2549506aed4c04d5e96779 | |||||||||||||||||||
| 686606 | G-Genito urinary system and sex hormones (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:45 | 2024-07-08 16:19:07 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | g_genito_urinary_system_and_sex_hormones__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
68aa58739608ea001f71fe2ed6e20bd7 | 7e868c4c1f63ff675d452b316eb94383 | |||||||||||||||||||
| 686605 | G-Genito urinary system and sex hormones (Sales: Million US$, purchasing power parity) | million US$ | 2023-05-04 14:12:45 | 2024-07-08 16:19:07 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | g_genito_urinary_system_and_sex_hormones__sales__million_usd__purchasing_power_parity | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__million_usd__purchasing_power_parity | 1 | [] |
float | [] |
b907817416a78c942f11ecd2b0778571 | 0dac2ae8de05a1d899ee2b0737da9d2d | |||||||||||||||||||
| 686604 | G-Genito urinary system and sex hormones (Sales: Million US$ at exchange rate) | million US$ | 2023-05-04 14:12:45 | 2024-07-08 16:19:07 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million US$"
} |
0 | g_genito_urinary_system_and_sex_hormones__sales__million_usd_at_exchange_rate | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__million_usd_at_exchange_rate | 1 | [] |
float | [] |
b26d599cd86483305d840f56e6816805 | 1fcd239f4b3e1f6f537b95e8bb46f513 | |||||||||||||||||||
| 686603 | C10-Lipid modifying agents (Sales: US$ (exchange rate) per capita) | US$ per capita | 2023-05-04 14:12:45 | 2024-07-08 16:19:07 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "US$ per capita"
} |
0 | c10_lipid_modifying_agents__sales__usd__exchange_rate__per_capita | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#c10_lipid_modifying_agents__sales__usd__exchange_rate__per_capita | 1 | [] |
float | [] |
2f0439bc8b2b69ed716bf2c2fe0f2fea | acff4d96c8ea0dd33437477847013f42 | |||||||||||||||||||
| 686602 | C10-Lipid modifying agents (Sales: % of total sales) | % | 2023-05-04 14:12:45 | 2024-07-08 16:19:07 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "%"
} |
0 | c10_lipid_modifying_agents__sales__pct_of_total_sales | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#c10_lipid_modifying_agents__sales__pct_of_total_sales | 1 | [] |
float | [] |
ac4e33d47a039b59d51253d98aa2d789 | 27cdb73e055b1a8e21f2a326061a8ac6 | |||||||||||||||||||
| 686601 | G-Genito urinary system and sex hormones (Sales: Million of national currency units) | million of national currency units | 2023-05-04 14:12:45 | 2024-07-08 16:19:07 | 2010-2021 | Health: Pharmaceutical Market (OECD, 2022) 5996 | OECD (2022) 29569 | {
"unit": "million of national currency units"
} |
0 | g_genito_urinary_system_and_sex_hormones__sales__million_of_national_currency_units | grapher/oecd/2023-05-01/health_pharma_market/health_pharma_market#g_genito_urinary_system_and_sex_hormones__sales__million_of_national_currency_units | 1 | [] |
float | [] |
0d10567d084133f4d60d5fe3be5cfa75 | 5138cf54bb2c8503e829357c6cf89f85 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE "variables" (
"id" INTEGER PRIMARY KEY AUTOINCREMENT,
"name" VARCHAR(750) NULL ,
"unit" VARCHAR(255) NOT NULL ,
"description" TEXT NULL ,
"createdAt" DATETIME NOT NULL DEFAULT CURRENT_TIMESTAMP ,
"updatedAt" DATETIME NULL ,
"code" VARCHAR(255) NULL ,
"coverage" VARCHAR(255) NOT NULL ,
"timespan" VARCHAR(255) NOT NULL ,
"datasetId" INTEGER NOT NULL ,
"sourceId" INTEGER NULL ,
"shortUnit" VARCHAR(255) NULL ,
"display" TEXT NOT NULL ,
"columnOrder" INTEGER NOT NULL DEFAULT '0' ,
"originalMetadata" TEXT NULL ,
"grapherConfigAdmin" TEXT NULL ,
"shortName" VARCHAR(255) NULL ,
"catalogPath" VARCHAR(767) NULL ,
"dimensions" TEXT NULL ,
"schemaVersion" INTEGER NOT NULL DEFAULT '1' ,
"processingLevel" VARCHAR(30) NULL ,
"processingLog" TEXT NULL ,
"titlePublic" VARCHAR(512) NULL ,
"titleVariant" VARCHAR(255) NULL ,
"attributionShort" VARCHAR(512) NULL ,
"attribution" TEXT NULL ,
"descriptionShort" TEXT NULL ,
"descriptionFromProducer" TEXT NULL ,
"descriptionKey" TEXT NULL ,
"descriptionProcessing" TEXT NULL ,
"licenses" TEXT NULL ,
"license" TEXT NULL ,
"grapherConfigETL" TEXT NULL ,
"type" TEXT NULL ,
"sort" TEXT NULL ,
"dataChecksum" VARCHAR(64) NULL ,
"metadataChecksum" VARCHAR(64) NULL,
FOREIGN KEY("datasetId") REFERENCES "datasets" ("id") ON UPDATE RESTRICT ON DELETE RESTRICT,
FOREIGN KEY("sourceId") REFERENCES "sources" ("id") ON UPDATE RESTRICT ON DELETE RESTRICT
);
CREATE UNIQUE INDEX "idx_catalogPath" ON "variables" ("catalogPath");
CREATE UNIQUE INDEX "unique_short_name_per_dataset" ON "variables" ("shortName", "datasetId");
CREATE UNIQUE INDEX "variables_code_fk_dst_id_7bde8c2a_uniq" ON "variables" ("code", "datasetId");
CREATE INDEX "variables_datasetId_50a98bfd_fk_datasets_id" ON "variables" ("datasetId");
CREATE UNIQUE INDEX "variables_name_fk_dst_id_f7453c33_uniq" ON "variables" ("name", "datasetId");
CREATE INDEX "variables_sourceId_31fce80a_fk_sources_id" ON "variables" ("sourceId");